Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Fred Hutchinson Cancer Research Center
Seattle, Washington
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 158
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Lawrence Corey | Conflict of Interest | Immune Design Corporation | >$600,000 | 2015 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | >$600,000 | 2016 |
| Stanley Riddell | Conflict of Interest | Juno Therapeutics | >$600,000 | 2016 |
| Stanley Riddell | Conflict of Interest | Juno Therapeutics | >$600,000 | 2015 |
| Mads Daugaard | Conflict of Interest | VAR2 Pharmaceuticals | >$600,000 | 2019 |
| Phillip Greenberg | Conflict of Interest | Juno Therapeutics | >$600,000 | 2016 |
| Michael Jensen | Conflict of Interest | Juno Therapeutics | >$600,000 | 2015 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | >$600,000 | 2016 |
| Douglas G. McNeel | Conflict of Interest | Madison Vaccines Inc | $400,000 - $449,999 | 2014 |
| Colleen Delaney | Conflict of Interest | Nohla Therapeutics | $250,000 - $299,999 | 2016 |
| Colleen Delaney | Conflict of Interest | Nohla Therapeutics | $250,000 - $299,999 | 2017 |
| Klaus Frueh | Conflict of Interest | Vir Biotechnology, Inc. | $150,000 - $199,999 | 2017 |
| Harlan Robins | Conflict of Interest | Adaptive Biotechnologies Corporation | $100,000 - $149,999 | 2014 |
| Harlan Robins | Conflict of Interest | Adaptive Biotechnologies Corporation | $100,000 - $149,999 | 2014 |
| James Olson | Conflict of Interest | Presage Biosciences | $100,000 - $149,999 | 2016 |
| James Olson | Conflict of Interest | Presage Biosciences | $100,000 - $149,999 | 2015 |
| Harlan Robins | Conflict of Interest | Adaptive Biotechnologies Co | $100,000 - $149,999 | 2013 |
| Jason Bielas | Conflict of Interest | Grail, Inc. | $80,000 - $99,999 | 2017 |
| James Olson | Conflict of Interest | Presage Biosciences | $80,000 - $99,999 | 2015 |
| James Olson | Conflict of Interest | Presage Biosciences | $80,000 - $99,999 | 2015 |
| Jason Bielas | Conflict of Interest | Grail, Inc. | $80,000 - $99,999 | 2017 |
| Jason Bielas | Conflict of Interest | Grail, Inc. | $80,000 - $99,999 | 2016 |
| Jason Bielas | Conflict of Interest | Grail, Inc | $80,000 - $99,999 | 2018 |
| Jason Bielas | Conflict of Interest | Grail, Inc. | $80,000 - $99,999 | 2017 |
| Shelly Heimfeld | Conflict of Interest | Nohla Therapeutics | $80,000 - $99,999 | 2016 |
| Shelly Heimfeld | Conflict of Interest | Nohla Therapeutics | $80,000 - $99,999 | 2016 |
| Phillip Greenberg | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2014 |
| Stanley Riddell | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2018 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2018 |
| Stanley Riddell | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2014 |
| Stanley Riddell | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2016 |
| Michael Jensen | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2014 |
| Mads Daugaard | Conflict of Interest | VAR2 Pharmaceuticals | $60,000 - $79,999 | 2019 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2016 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2014 |
| Philip Greenberg | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2018 |
| James Olson | Conflict of Interest | Presage Biosciences | $40,000 - $59,999 | 2013 |
| James Olson | Conflict of Interest | Blaze Biosciences | $40,000 - $59,999 | 2018 |
| Christopher Carlson | Conflict of Interest | Adpative Biotechnologies Corporation | $40,000 - $59,999 | 2014 |
| Scott Hansen | Conflict of Interest | Vir Biotechnology, Inc. | $40,000 - $59,999 | 2017 |
| James Olson | Conflict of Interest | Blaze Biosciences | $40,000 - $59,999 | 2014 |
| Evan Yu | Conflict of Interest | Dendreon | $40,000 - $59,999 | 2016 |
| Sunil R. Hingorani | Conflict of Interest | Halozyme | $20,000 - $39,999 | 2016 |
| Sunil Hingorani | Conflict of Interest | Halozyme | $20,000 - $39,999 | 2016 |
| Douglas G. McNeel | Conflict of Interest | Madison Vaccines Inc | $20,000 - $39,999 | 2014 |
| Sunil Hingorani | Conflict of Interest | Halozyme | $10,000 - $19,999 | 2017 |
| Daniel Streblow | Conflict of Interest | TomegaVax, Inc. | $10,000 - $19,999 | 2015 |
| Irwin Bernstein | Conflict of Interest | Nohla Therapeutics | $10,000 - $19,999 | 2016 |
| Sunil Hingorani | Conflict of Interest | Halozyme | $10,000 - $19,999 | 2017 |
| Michael Jensen | Conflict of Interest | City of Hope | $10,000 - $19,999 | 2014 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.